SRPT
Sarepta Therapeutics Inc
Price:  
18.24 
USD
Volume:  
2,484,362.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT EV/EBITDA

27.6%
Upside

As of 2025-07-06, the EV/EBITDA ratio of Sarepta Therapeutics Inc (SRPT) is -51.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SRPT's latest enterprise value is 2,690.05 mil USD. SRPT's TTM EBITDA according to its financial statements is -51.77 mil USD. Dividing these 2 quantities gives us the above SRPT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.4x - 13.1x 11.7x
Forward P/E multiples 11.7x - 32.0x 16.2x
Fair Price (14.63) - 130.43 23.27
Upside -180.2% - 615.1% 27.6%
18.24 USD
Stock Price
23.27 USD
Fair Price

SRPT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -51.96
2025-07-02 -51.87
2025-07-01 -50.95
2025-06-30 -49.80
2025-06-27 -49.81
2025-06-26 -50.04
2025-06-25 -50.48
2025-06-24 -53.36
2025-06-23 -53.16
2025-06-20 -55.45
2025-06-18 -56.76
2025-06-17 -58.26
2025-06-16 -57.09
2025-06-13 -86.02
2025-06-12 -88.16
2025-06-11 -89.11
2025-06-10 -91.50
2025-06-09 -92.72
2025-06-06 -98.98
2025-06-05 -91.77
2025-06-04 -92.39
2025-06-03 -91.12
2025-06-02 -88.98
2025-05-30 -88.71
2025-05-29 -90.63
2025-05-28 -88.01
2025-05-27 -90.13
2025-05-23 -89.28
2025-05-22 -90.97
2025-05-21 -93.36
2025-05-20 -93.25
2025-05-19 -89.36
2025-05-16 -86.49
2025-05-15 -84.29
2025-05-14 -85.18
2025-05-13 -86.05
2025-05-12 -86.38
2025-05-09 -86.19
2025-05-08 -86.66
2025-05-07 -87.04
2025-05-06 -106.08
2025-05-05 -138.18
2025-05-02 -137.90
2025-05-01 -136.51
2025-04-30 -135.79
2025-04-29 -132.85
2025-04-28 -134.10
2025-04-25 -132.07
2025-04-24 -134.57
2025-04-23 -130.27